Stock ALRN AILERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 03:57:47 2024-05-02 pm EDT 		5-day change 1st Jan Change
3.805 USD -8.53% Intraday chart for Aileron Therapeutics, Inc. -24.00% +24.65%
May. 01 Transcript : Aileron Therapeutics, Inc. - Special Call
May. 01 Aileron Therapeutics, Inc. Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15.94 42.31 50.98 10.76 14.89 70.61 - -
Enterprise Value (EV) 1 15.94 42.31 50.98 10.76 14.89 70.61 70.61 70.61
P/E ratio -0.48 x -1.7 x -1.94 x -0.39 x -0.89 x -1.15 x -2.3 x -3.3 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA -534,724 x -2,080,953 x - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 1,391 2,034 4,529 4,541 4,886 16,973 - -
Reference price 2 11.46 20.80 11.26 2.370 3.049 4.160 4.160 4.160
Announcement Date 3/30/20 3/24/21 3/28/22 3/20/23 4/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - - -
EBITDA -29.8 -20.33 - - - - - -
EBIT 1 -29.96 -20.5 -26.6 -27.65 -16.28 -23.48 -27.67 -32.57
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 -29.37 -21.16 -26.16 -27.33 -15.73 -23.06 -26.96 -31.37
Net income 1 -29.37 -21.16 -26.16 -27.33 -15.73 -23.06 -26.96 -31.37
Net margin - - - - - - - -
EPS 2 -24.00 -12.20 -5.800 -6.020 -3.420 -3.620 -1.810 -1.260
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/30/20 3/24/21 3/28/22 3/20/23 4/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - -
EBIT 1 -6.791 -6.816 -8.421 -8.041 -6.482 -4.703 -5.011 -2.08 -7.29 -5.019 -5.548 -6.173 -6.741
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -6.704 -6.799 -8.422 -7.992 -6.368 -4.547 -4.779 -1.787 -7.339 -5.019 -5.548 -6.072 -6.416
Net income 1 -6.704 -6.799 -8.422 -7.992 -6.368 -4.547 -4.779 -1.787 -7.339 -5.019 -5.548 -6.072 -6.416
Net margin - - - - - - - - - - - - -
EPS 2 -1.400 -1.600 -1.800 -1.800 -1.400 -1.020 -1.050 -0.3900 -1.540 -1.020 -1.130 -0.8200 -0.6500
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/12/21 3/28/22 5/5/22 8/15/22 11/1/22 3/20/23 5/8/23 8/11/23 4/15/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 0.15 0.01 0.16 - - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/30/20 3/24/21 3/28/22 3/20/23 4/15/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.16 USD
Average target price
19 USD
Spread / Average Target
+356.73%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
AILERON THERAPEUTICS, INC. Stock Aileron Therapeutics, Inc.
+24.65% 70.61M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.76% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+6.40% 97.47B
ARGENX SE Stock argenx SE
+5.71% 22.25B
BIONTECH SE Stock BioNTech SE
-12.63% 21.68B
GENMAB A/S Stock Genmab A/S
-9.70% 18.2B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.20% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.94% 14.39B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.64% 12.37B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ALRN Stock
  4. Financials Aileron Therapeutics, Inc.